Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macitentan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02651272
What this trial is testing

Macitentan in Pulmonary Hypertension of Sickle Cell Disease

Who this might be right for
Pulmonary HypertensionSickle Cell Disease
Boston University 4
Not applicableStudy completedNCT04567602
What this trial is testing

Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag

Who this might be right for
Pulmonary Arterial Hypertension
Janssen-Cilag S.p.A. 372
Testing effectiveness (Phase 2)Ended earlyNCT03714815
What this trial is testing

A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Who this might be right for
Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Actelion 91
Early research (Phase 1)Study completedNCT04963439
What this trial is testing

Two Macitentan Pediatric Formulations in Healthy Adult Participants

Who this might be right for
Healthy
Actelion 16
Post-approval studies (Phase 4)WithdrawnNCT02893176
What this trial is testing

Macitentan in the Treatment of Organ Rejection After Lung Transplantation

Who this might be right for
Lung Transplant Rejection
University of California, Los Angeles
Large-scale testing (Phase 3)Study completedNCT02932410
What this trial is testing

Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 165
Post-approval studies (Phase 4)Looking for participantsNCT07147114
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

Who this might be right for
Combined Pre- and Post-capillary Pulmonary HypertensionCpcPHHFmrEF+2 more
Gachon University Gil Medical Center 64
Large-scale testing (Phase 3)Study completedNCT03422328
What this trial is testing

A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.

Who this might be right for
Pulmonary Arterial HypertensionChronic Thromboembolic Pulmonary Hypertension
Actelion 151
Testing effectiveness (Phase 2)Study completedNCT02060721
What this trial is testing

Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension

Who this might be right for
Chronic Thromboembolic Pulmonary Hypertension
Actelion 76
Testing effectiveness (Phase 2)Study completedNCT03153111
What this trial is testing

Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Actelion 143
Not applicableLooking for participantsNCT01347216
What this trial is testing

COMPERA / COMPERA-KIDS

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension (PH)
Technische Universität Dresden 14,000
Large-scale testing (Phase 3)Study completedNCT03904693
What this trial is testing

Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Actelion 187
Post-approval studies (Phase 4)Study completedNCT02310672
What this trial is testing

REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 89
Large-scale testing (Phase 3)Study completedNCT03153137
What this trial is testing

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Who this might be right for
Congenital Heart Disease
Actelion 142
Early research (Phase 1)Study completedNCT06553937
What this trial is testing

Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg

Who this might be right for
PAH
Humanis Saglık Anonim Sirketi 30
Not applicableStudy completedNCT02565030
What this trial is testing

Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome

Who this might be right for
Chronic Thromboembolic Pulmonary HypertensionIdiopathic Pulmonary Arterial Hypertension
Sheffield Teaching Hospitals NHS Foundation Trust 1,200
Large-scale testing (Phase 3)Study completedNCT05167825
What this trial is testing

Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Janssen Pharmaceutical K.K. 7
Testing effectiveness (Phase 2)Study completedNCT02070991
What this trial is testing

Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction

Who this might be right for
Pulmonary Hypertension
Actelion 63
Large-scale testing (Phase 3)Ended earlyNCT01847014
What this trial is testing

Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 4
Large-scale testing (Phase 3)Ended earlyNCT02081690
What this trial is testing

A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and Spain

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 160
Next Page